CAS RN: 1263316-20-6
2-(1-Boc-2-piperazinyl)-2-propanol
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
97% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20250618
100mg / 250mg / 1g
Out of stock
8-10 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 1263316-20-6
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥95%
0
Out of Stock
Beijing
Inquiry
1263316-20-6 / tert-butyl 2-(2-hydroxypropan-2-yl)piperazine-1-carboxylate
Standard CAS: 1263316-20-6
Multi CAS: No
Basic Information
copy
CAS
1263316-20-6 copy
Multi CAS
No copy
Molecular Formula
C12H24N2O3 copy
Molecular Weight
244.330000 copy
Exact Mass
244.178693 copy
SMILES
CC(C)(C)OC(=O)N1CCNCC1C(C)(C)O copy
InChI
InChI=1S/C12H24N2O3/c1-11(2,3)17-10(15)14-7-6-13-8-9(14)12(4,5)16/h9,13,16H,6-8H2,1-5H3 copy
InChIKey
ARLIDHMCHOKZLF-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
17 copy
Fraction Csp3
0.92 copy
Rotatable bonds
1 copy
H-bond acceptors
4 copy
H-bond donors
2 copy
Molar refractivity
65.9 copy
TPSA
61.8 copy
LogP / Solubility
WLOGP
0.97 copy
MLOGP
0.86 copy
XLogP3
0.5 copy
Consensus LogP
0.78 copy
Log S (ESOL)
-1.9 copy
Class (ESOL)
Soluble copy
Log S (Ali)
-2.26 copy
Class (Ali)
Moderately soluble copy
Log S (SILICOS-IT)
-2.17 copy
Class (SILICOS-IT)
Moderately soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-3.52 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
2 copy